|
ZNF780A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.995600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.678300E-02 |
| Normal-vs-Stage2 |
3.447200E-01 |
| Normal-vs-Stage3 |
5.264000E-02 |
| Normal-vs-Stage4 |
1.123390E-01 |
| Stage1-vs-Stage2 |
5.380600E-01 |
| Stage1-vs-Stage3 |
6.945600E-01 |
| Stage1-vs-Stage4 |
8.406600E-01 |
| Stage2-vs-Stage3 |
4.979800E-01 |
| Stage2-vs-Stage4 |
6.181400E-01 |
| Stage3-vs-Stage4 |
9.578800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.459800E-02 |
| Normal-vs-AfricanAmerican |
2.335200E-01 |
| Normal-vs-Asian |
1.391800E-02 |
| Caucasian-vs-AfricanAmerican |
3.973400E-01 |
| Caucasian-vs-Asian |
3.954000E-01 |
| AfricanAmerican-vs-Asian |
1.622000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.351600E-02 |
| Normal-vs-Female |
5.432800E-01 |
| Male-vs-Female |
3.783500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.618370E-02 |
| Normal-vs-Extreme_Weight |
1.482410E-03 |
| Normal-vs-Obese |
5.227800E-01 |
| Normal-vs-Extreme_Obese |
1.694320E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.442400E-01 |
| Normal_Weight-vs-Obese |
7.744200E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.290800E-01 |
| Extreme_Weight-vs-Obese |
4.722500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.414400E-01 |
| Obese-vs-Extreme_Obese |
1.027420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.097600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.695600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.901800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.244000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.235400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.281850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.639990E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.164800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.308200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.658770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.936040E-01 |
| Normal-VS-Type2 PRCC |
3.71639999999784E-05 |
| Normal-VS-KIRP CIMP |
1.788610E-01 |
| Normal-VS-Unclassified PRCC |
8.822200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.184770E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.743000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.925400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.019000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.779990E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.175200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.769210E-04 |
| Normal-vs-N1 |
3.102600E-01 |
| Normal-vs-N2 |
4.742100E-02 |
| N0-vs-N1 |
5.956200E-02 |
| N0-vs-N2 |
4.718200E-01 |
| N1-vs-N2 |
1.851390E-01 |
|
|
